Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers

Immune checkpoint blockade with specific antibodies can accelerate anti-tumor immunity, resulting in clinical responses in patients with various types of cancer. However, these antibodies achieve only partial tumor regression. Thus, a wide variety of treatment combinations based on programmed death-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Osawa, Yosuke, Kojika, Ekumi, Nishikawa, Koji, Kimura, Masamichi, Osakaya, Shigenori, Miyauchi, Hiromi, Kanto, Tatsuya, Kawakami, Yutaka, Kimura, Kiminori
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2019
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508964/
https://ncbi.nlm.nih.gov/pubmed/31105882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26892
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge